32 studies found for:    " June 24, 2009":" July 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" June 24, 2009":" July 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
Conditions: HIV Positive;   Anal Condylomata;   Anal Warts;   HIV Infections
Interventions: Drug: Saline;   Drug: Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
2 Completed Integration of Family Planning and HIV Services in Tanzania
Conditions: HIV Infection;   HIV Infections
Intervention: Behavioral: Facilitated Referral
3 Active, not recruiting HIV Viral Load Monitoring in Resource-Poor Settings
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: HIV-1 viral load testing
4 Unknown  Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)
Conditions: HIV;   Lung;   HIV Infections
Intervention: Behavioral: Smoking Cessation
5 Completed Switch From Tenofovir to Raltegravir for Low Bone Mineral Density
Conditions: HIV;   Osteopenia;   Osteoporosis;   HIV Infections
Intervention: Drug: Raltegravir
6 Active, not recruiting Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
Conditions: Pediatric HIV;   HIV Infections
Intervention: Drug: Boosted Atazanavir
7 Unknown  Preparing for Adolescent HIV Vaccine Trials in South Africa:
Conditions: HIV Infection;   HIV Infections
Intervention:
8 Withdrawn Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
Conditions: HIV Infection;   Pregnancy;   Breastfeeding;   HIV Infections
Interventions: Drug: Efavirenz-Tenofovir-Emtricitabine;   Drug: Zidovudine-Lamivudine-Lopinavir/Ritonavir
9 Completed Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Behavioral: Tailored Information Program for Safer Sex
10 Completed Study of Bone Disease in Older HIV-infected Adults
Conditions: Osteopenia;   Osteoporosis;   HIV Infection;   Aging;   HIV Infections
Intervention:
11 Completed Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: raltegravir QD;   Drug: atazanavir;   Drug: lamivudine (or emtricitabine)
12 Completed Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: maraviroc
13 Terminated Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
Conditions: HIV1 Infection;   HIV Infections
Intervention:
14 Completed Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
Conditions: Herpes Simplex Type Two Infection;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
15 Completed IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients
Condition: HIV Infections
Interventions: Drug: Isentress®;   Drug: Celsentri®
16 Completed Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya
Condition: HIV Infections
Intervention: Procedure: Integrated ANC, PMTCT, HIV services
17 Completed Effect of Antacids on the Pharmacokinetics of Raltegravir
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: antacid
18 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
Condition: HIV Infection
Interventions: Drug: FTC/TDF;   Drug: Placebo
19 Unknown  Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Conditions: Cervical Cancer Screening;   HIV Infections
Intervention:
20 Unknown  Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz
Conditions: Sleep Disorders;   HIV Infections
Interventions: Drug: Raltegravir for the first 2 weeks;   Drug: Efavirenz for the last 2 weeks;   Drug: Efavirenz for the first 2 weeks;   Drug: Raltegravir for the last 2 weeks

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years